Detalhe da pesquisa
1.
Combination PEG-IFN a-2b/ribavirin therapy following treatment of hepatitis C virus-associated hepatocellular carcinoma is capable of improving hepatic functional reserve and survival.
Hepatogastroenterology
; 59(114): 529-32, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22024226
2.
Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Hepatogastroenterology
; 59(119): 2260-3, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23435141
3.
Failure to achieve 2-log10 viral decrease in first four weeks of peg-IFNalpha-2b plus ribavirin therapy for chronic hepatitis C with genotype 1b and high viral titer is useful in predicting non-response: evaluation of response-guided therapy.
Hepatogastroenterology
; 58(107-108): 965-70, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21830425
4.
Complete early virological response was highly achieved by double filtration plasmapheresis plus IFN-beta induction therapy for HCV-1b patients with relapse or no response after previous IFN therapy.
Ther Apher Dial
; 15(4): 400-5, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21884476